Introduction
Tech powerhouse Oracle (ORCL) announced the purchase of the health records company Cerner (CERN) through an all-cash tender offer of $95 per share. With this video I will illustrate whether (or not) Oracle purchased Cerner at an attractive valuation. Moreover, we will discuss the potential acceleration in growth that Cerner might provide to Oracle. But perhaps most importantly, this video provides clear and undeniable evidence of the fundamental relationship between a company’s stock price and its operating results over the long run. The key to value investing is positioning yourself to be able to participate fully in the results the business produces on its shareholders’ behalf.
FAST Graphs Analyze Out Loud Video on Cerner and Oracle
Try FAST Graphs for FREE Today!
SUBSCRIBE to our YouTube Channel
Click here for our Research Articles
Disclosure: Long ORCL
Disclaimer: The opinions in this document are for informational and educational purposes only and should not be construed as a recommendation to buy or sell the stocks mentioned or to solicit transactions or clients. Past performance of the companies discussed may not continue and the companies may not achieve the earnings growth as predicted. The information in this document is believed to be accurate, but under no circumstances should a person act upon the information contained within. We do not recommend that anyone act upon any investment information without first consulting an investment advisor as to the suitability of such investments for his specific situation.